SFX by Ex Libris Inc.

Title:	A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Source:	Nature [0028-0836] Johannessen, C M yr:2013

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Poulikakos, Poulikos I. "RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF." Nature 464.7287 (2010): 427-430.
description	2.	Johannessen, Cory M. "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation." Nature 468.7326 (2010): 968-972.
description	3.	Huang, Franklin W. "Highly Recurrent TERT Promoter Mutations in Human Melanoma." Science 339.6122 (2013): 957-959.
description	4.	Davies, H. "Mutations of the BRAF gene in human cancer." Nature 417.6892 (2002): 949-54.
description	5.	Marquette, A. "ERK and PDE4 cooperate to induce RAF isoform switching in melanoma." Nature structural & molecular biology 18.5 (2011): 584-591.
description	6.	Stokoe, G. "RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth." Nature 464.7287 (2010): 431-435.
description	7.	Horn, R. "TERT Promoter Mutations in Familial and Sporadic Melanoma." Science 339.6122 (2013): 959-961.
description	8.	Nazarian, R. "Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation." Nature 468.7326 (2010): 973-977.
description	9.	Chapman, Paul B. "Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation." The New England journal of medicine 364.26 (2011): 2507-2516.
description	10.	Gray-Schopfer, V. "Melanoma biology and new targeted therapy." Nature 445.7130 (2007): 851-7.
description	11.	Poulikakos, Poulikos I. "RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)." Nature 480.7377 (2011): 387-390.
description	12.	Curtin, John A A. "Distinct sets of genetic alterations in melanoma." New England Journal of Medicine, The 353.20 (2005): 2135-47.
description	13.	Joseph, Eric W. "The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner." Proceedings of the National Academy of Sciences of the United States of America 107.33 (2010): 14903-14908.
description	14.	Pollock, Pamela M M. "High frequency of BRAF mutations in nevi." Nature genetics 33.1 (2003): 19-20.
description	15.	Wan, Paul T C T. "Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF." Cell 116.6: 855-867.
description	16.	Flaherty, Keith T. "Inhibition of Mutated, Activated BRAF in Metastatic Melanoma." New England Journal of Medicine 363.9 (2010): 809-819.
description	17.	Halaban, R. "PLX4032, a Selective BRAF(V600E) Kinase Inhibitor, Activates the ERK Pathway and Enhances Cell Migration and Proliferation of BRAF(WT) Melanoma Cells." Pigment cell & melanoma research 23.2 (2010): 190-200.
description	18.	Thomas, Roman K. "High-throughput oncogene mutation profiling in human cancer." Nature genetics 39.4 (2007): 567-51.
description	19.	Daniels, Anthony B. "High Throughput Mass Spectrometry-Based Mutation Profiling of Primary Uveal Melanoma." Investigative ophthalmology & visual science 53.11 (2012): 6991-6996.
description	20.	HODIS, E. "A Landscape of Driver Mutations in Melanoma." Cell 150.2 (2012): 251-263.